Emiel De Jaeghere
- Work address
-
C. Heymanslaan 10, ingang 12 - verdieping 6
9000 Gent - Emiel.DeJaeghere@UGent.be
- ORCID iD
-
0000-0001-6314-6179
Show
Sort by
-
- Journal Article
- A1
- open access
Mental health and quality of life among patients with cancer during the SARS-CoV-2 pandemic : results from the longitudinal ONCOVID survey study
-
Pembrolizumab, SBRT, and immunomodulation for recurrent and/or refractory cervical or endometrial carcinoma
-
- Journal Article
- A1
- open access
Risk of thrombo-embolic events in ovarian cancer : does bevacizumab tilt the scale? A systematic review and meta-analysis
-
How are OCD patients and family members dealing with the waxing and waning pattern of the COVID-19 pandemic? Results of a longitudinal observational study
-
Splenic hematopoietic and stromal cells in cancer progression
-
Splenic 18F-FDG uptake on baseline PET/CT is associated with oncological outcomes and tumor immune state in uterine cervical cancer
-
Immunologic impact of chemoradiation in cervical cancer and how immune cell infiltration could lead towards personalized treatment
-
- Journal Article
- A1
- open access
The nocebo effect and tobacco control : first, do no harm?
-
Immunologic impact of chemoradiation in cervical cancer and how immune cell infiltration could lead towards personalized treatment
-
Is locally advanced cervix adenocarcinoma less radiosensitive than squamous cell carcinoma?